Enliven Therapeutics (ELVN) Earnings Date & Reports

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELVN is expected to report earnings to fall 7.72% to -52 cents per share on August 07

Enliven Therapeutics ELVN Stock Earnings Reports

Q2'25

Est.

$-0.53

Q1'25

Missed

by $0.07

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.14

The last earnings report on May 14 showed earnings per share of -56 cents, missing the estimate of -50 cents. With 133.25K shares outstanding, the current market capitalization sits at 827.31M.

View a ticker or compare two or three

Compare

ELVN